Sessioni Simposi

Pharmacovigilance and Risk Management Strategies Martedì 27 Ottobre 2015 14.00-15.30
The clinical pharmacology of heart failure: general aspects and special situations (SIF-ITAHFA joint Symposium) Martedì 27 Ottobre 2015 15.00-17.00
Therapeutic cannabis Martedì 27 Ottobre 2015 15.30-17.00
Immuno-oncology: future perspectives in solid tumor treatment Martedì 27 Ottobre 2015 16.00-17.00
Retinal diseases: the appropriate governance challenges Mercoledì 28 Ottobre 2015 11.00-12.00
Diabetes: improvement of the care pathways and evaluation of direct and indirect costs (SIF-AMD-ISPOR Italy Rome Chapter-SIMG Joint Symposium) Mercoledì 28 Ottobre 2015 11.00-13.00
From the past to the future of Nutraceuticals Mercoledì 28 Ottobre 2015 11.00-12.30
Position papers on biosimilars Mercoledì 28 Ottobre 2015 11.30-12.00
Multiple Sclerosis: state of the art and future perspectives (SIF-SIN joint symposium) Mercoledì 28 Ottobre 2015 12.00-13.00
Combination therapy in controlling hypercholesterolemia and cardiovascular prevention (SIF -SITeCS joint symposium) Mercoledì 28 Ottobre 2015 12.00-13.00
The Neuroimmune Pharmacology of Multiple Sclerosis (MS) Mercoledì 28 Ottobre 2015 14.00-15.00
T-Cell engagement strategies: a new era for ALL (SIF-SIE joint symposium) Mercoledì 28 Ottobre 2015 14.00-15.00
New approaches in lipid-lowering therapy (SIF-SISA joint symposium) Mercoledì 28 Ottobre 2015 14.00-16.00
New drugs for type 2 diabetes and obesity treatment Mercoledì 28 Ottobre 2015 14.00-16.00
Drugs with expired patent (SIF-FIMMG joint symposium) Mercoledì 28 Ottobre 2015 14.00-15.00
The virtuous circle pharmacology-clinics: new perspectives for the treament of heart failure (SIF-FADOI joint symposium) Mercoledì 28 Ottobre 2015 14.00-16.00
Phosphodiesterase 4 modulation in immune-mediated diseases Mercoledì 28 Ottobre 2015 15.00-16.00
Innovation in pharmacological treatment in oncohematology (SIF-SIE joint symposium) Mercoledì 28 Ottobre 2015 15.00-16.00
The role of adherence in the success of pharmacological treatment Mercoledì 28 Ottobre 2015 15.30-17.30
IL-17-mediated inflammation and its clinical manifestations Mercoledì 28 Ottobre 2015 16.00-17.00
"Which willingness to pay?" Mercoledì 28 Ottobre 2015 16.00-17.30
Pathophysiology and pharmacology of the FPR2 receptor and its ligands Mercoledì 28 Ottobre 2015 16.00-17.30
Industry-academia partnerships: are we ready to meet? Mercoledì 28 Ottobre 2015 16.00-17.30
Drugs in primary care Mercoledì 28 Ottobre 2015 17.00-19.00
Research and development of orphan drugs (SIF-SSFA joint symposium) Mercoledì 28 Ottobre 2015 17.30-19.00
Advances in retinal pharmacology and clinical perspectives (SIF-SIR Joint Symposium) Mercoledì 28 Ottobre 2015 17.30-19.00
Alzheimer's disease and anti-Amyloid β immunotherapy clinical studies. A critical review (SIF-SINDEM joint symposium) Mercoledì 28 Ottobre 2015 17.30-19.00
Old and new drugs in the modulation of reward and emotional behavior Mercoledì 28 Ottobre 2015 17.30-19.00
Targeting Inflammation to Reduce CVD Risk: a Realistic Clinical Prospect? (Joint Symposium of the British Pharmacological Society (BPS) and the Italian Society of Pharmacology (SIF) with the contribute of the Federation of European Pharmacological Societies (EPHAR)) Mercoledì 28 Ottobre 2015 8.30-10.00
The purinergic system as a new, promising target to treat human diseases (SIF-Italian Purine Club Joint Symposium) Mercoledì 28 Ottobre 2015 8.30-10.00
TRP channels and other targets Mercoledì 28 Ottobre 2015 8.30-10.00
Sarcopenia: from pathophysiology to experimental studies to define effective pharmacological approaches Mercoledì 28 Ottobre 2015 8.30-10.00
Anti-Gram positive antibiotics for the treatment of ABSSSI: evolution is pharmacokinetic! (SIF-SIC joint symposium) Giovedì 29 Ottobre 2015 09.00-10.00
Roundtable "New horizons in pharmacological research: between ethics and science" Giovedì 29 Ottobre 2015 11.00-13.00
PUFA n-3: evidences in cardiovascular prevention Giovedì 29 Ottobre 2015 14.00-15.00
Depression and cognitive symptoms: physiopathological, clinical and pharmacotherapeutic aspects Giovedì 29 Ottobre 2015 14.00-15.00
Recent advances on rifaximin pharmacology and therapeutics: more than just a simple antibiotic (SIF-AIGO joint symposium) Giovedì 29 Ottobre 2015 14.00-15.00
New perspectives on immunoinflammatory diseases Giovedì 29 Ottobre 2015 14.00-15.00
The state of clinical research: criticalities and future perspectives Giovedì 29 Ottobre 2015 14.00-16.00
How to maintain the long-term sustainability of pharmaceutical innovation: new drugs and new endopoints in oncology (SIF-AIOM joint symposium) Giovedì 29 Ottobre 2015 14.00-16.00
HCV hot topics: clinical benefits and financial impact in Italy Giovedì 29 Ottobre 2015 14.00-16.00
New horizons in IBD treatment: the anti-integrin therapies Giovedì 29 Ottobre 2015 15.00-16.00
SIF-SIC joint symposium\nNew perspectives and approaches in bacterial infections management Giovedì 29 Ottobre 2015 15.00-16.00
The impact of regional regulatory measures on biosimilars and bioequivalents adverse reactions reports Giovedì 29 Ottobre 2015 15.00-16.15
Therapeutic appropriateness in hypertensive patient (SIF-SIIA joint symposium) Giovedì 29 Ottobre 2015 16.00-18.00
The health and social effects of counterfeit drugs (SIF-SITOX joint symposium) Giovedì 29 Ottobre 2015 16.00-18.00
Oncology at a crossroad: the use of biomarkers in target therapy (SIF-AIOM joint symposium) Giovedì 29 Ottobre 2015 16.00-18.00
SIF-AIGO joint symposium\nUniqueness of biotechnological drugs development and production: regulatory, pharmacological and clinical aspects Giovedì 29 Ottobre 2015 16.30-17.30
Understanding new molecular pathways in the pathogenesis of neuropsychiatric disorders: animal models towards translational approaches Giovedì 29 Ottobre 2015 16.30-18.00
Therapeutics in spinal and central processing of pain and analgesia Giovedì 29 Ottobre 2015 16.30-18.00
Food for Thought: when unbalanced diets lead to unbalanced brains Giovedì 29 Ottobre 2015 16.30-18.00
New pharmacological approaches in the management of inflammatory processes Giovedì 29 Ottobre 2015 8.30-10.00
New recent advances on glutamate receptors and their role in CNS Giovedì 29 Ottobre 2015 8.30-10.00
Alzheimer's disease: key pathogenetic issues for novel therapeutic approaches Giovedì 29 Ottobre 2015 8.30-10.00
Estrogens and pathologies associated with ageing Giovedì 29 Ottobre 2015 8.30-10.00
Neuropsychopharmacological research today: great efforts, few candidates, frequent failures Giovedì 29 Ottobre 2015 8.30-10.00
Circulating Extracellular Vesicles: cellular mediators, biomarkers and therapeutic tools Giovedì 29 Ottobre 2015 8.30-10.00
Nicotine and nicotinic receptors: new advances in physiology and pharmacology Giovedì 29 Ottobre 2015 8.30-10.00
Pharmacology Teaching Venerdì 30 Ottobre 2015 09.00-10.30
Prevention of opioid drugs abuse Venerdì 30 Ottobre 2015 09.00-10.30
Rational use of antibiotics in paediatry Venerdì 30 Ottobre 2015 11.00-12.30
Overfeeding, dysmetabolism, inflammation and stress exposure as prominent actors in the drama of neuropsychiatric disorders: new insights for the development of novel therapies Venerdì 30 Ottobre 2015 8.30-10.00
Purinergic enzymes: role in inflammatory/immune responses and therapeutic implications (SIF-ITALIAN PURINE CLUB joint symposium) Venerdì 30 Ottobre 2015 8.30-10.30